Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
13.87
+0.26 (1.91%)
Nov 21, 2024, 12:23 PM EST - Market open
Embecta Employees
Embecta had 2,200 employees as of September 30, 2023. The number of employees increased by 300 or 15.79% compared to the previous year.
Employees
2,200
Change (1Y)
300
Growth (1Y)
15.79%
Revenue / Employee
$508,591
Profits / Employee
$31,682
Market Cap
800.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 2,200 | 300 | 15.79% |
| Sep 30, 2022 | 1,900 | -129 | -6.36% |
| Sep 30, 2021 | 2,029 | -298 | -12.81% |
| Sep 30, 2020 | 2,327 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Avanos Medical | 3,771 |
| Bioventus | 970 |
| Pacira BioSciences | 712 |
| Autolus Therapeutics | 471 |
| Cronos Group | 356 |
| Evolus | 273 |
| Pliant Therapeutics | 158 |
| Cullinan Therapeutics | 85 |
EMBC News
- 8 days ago - UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 8 days ago - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 14 days ago - embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell - GlobeNewsWire
- 2 months ago - embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes - GlobeNewsWire
- 3 months ago - embecta to Participate in Investor Events - GlobeNewsWire
- 3 months ago - Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results - GlobeNewsWire
- 3 months ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire